Flinton Capital Management’s Quest Diagnostics DGX Stock Holding History

Flinton Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$5.04M	Buy	47,040 +4,528	+11%	+$465K	0.16%	110
2019 Q2	$4.33M	Sell	42,512 -4,288	-9%	-$412K	0.14%	137
2019 Q1	$4.21M	Buy	46,800 +12,704	+37%	+$1.1M	0.14%	134
2018 Q4	$2.84M	Buy	34,096 +9,664	+40%	+$906K	0.11%	156
2018 Q3	$2.64M	Sell	24,432 -10,896	-31%	-$1.2M	0.08%	189
2018 Q2	$3.88M	Sell	35,328 -6,544	-16%	-$682K	0.13%	156
2018 Q1	$4.2M	Sell	41,872 -4,032	-9%	-$413K	0.14%	136
2017 Q4	$4.52M	Sell	45,904 -14,400	-24%	-$1.37M	0.15%	127
2017 Q3	$5.65M	Sell	60,304 -1,424	-2%	-$151K	0.2%	107
2017 Q2	$6.86M	Buy	61,728 +28,384	+85%	+$3M	0.25%	90
2017 Q1	$3.27M	Sell	33,344 -11,584	-26%	-$1.1M	0.13%	153
2016 Q4	$4.13M	Buy	+44,928	New	+$3.87M	0.18%	110

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Flinton Capital Management's DGX Position: Q3 2019 in Review

Flinton Capital Management increased its Quest Diagnostics (DGX) stake by 11% in Q3 2019, buying an estimated $465K and bringing the position to 47,040 shares worth $5.04M. The position accounts for 0.16% of the portfolio, ranked #110.

Flinton Capital Management first reported a position in DGX in Q4 2016 and has held it in 12 quarters since. The position peaked at $6.86M in Q2 2017. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

Flinton Capital Management held 47,040 shares of Quest Diagnostics worth $5.04M as of Q3 2019.
Flinton Capital Management bought 4,528 Quest Diagnostics shares in Q3 2019, an estimated $465K.
Quest Diagnostics made up 0.16% of Flinton Capital Management's portfolio in Q3 2019, its #110 holding.
Flinton Capital Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's Quest Diagnostics position peaked at $6.86M in Q2 2017.
676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.